The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
There's a pattern here guys - AVCT share price goes up, ODX share price goes down, Merchantbanker comes onto the AVCT board and knocks the company.
Not sure what a psychiatrist would make of his behavior but he has been doing this for months now.
Best just to ignore him - a bit like AW and Global really.
Guys, apologies from the AVCT board if our posters are winding you up.
My view is that as investors we are on thin ground with Vaccine news, and we don't need infighting - we need in-promoting as we all know from the share price drops we have all seen the last few weeks.
Can we ask people like CS and Usain to refrain from being negative unless they have substantive facts
Posted on the AVCT board as well
From AVCTs RNS this week (I suggest that you should read them..)
"Furthermore, we remain on track to submit the UK regulatory application, or CTA, for AVA6000 pro-doxorubicin before the end of the year to allow first-in-human trials of the pre|CISIONTM chemotherapy platform at several clinical trial sites in the UK early in 2021."
The only one that I am aware of is the Mologic test. My understanding is that they are slightly behind Avacta or at about the same stage, but there is very little info about the test available (they are not a publicly listed company).
@merchantbanker spouts lots of stuff (quite smelly normally!).
He has no idea why the AVCT price has gone up, but he is trying to big up ODX purporting to be knowledgeable and downing AVCT keeping his vendetta up (they even recognize this on the ODX board).
If we get a positive RNS tomorrow and price up, or no RNS tomorrow and price holds, he will stay quiet.
If no RNS and price drops, he'll be back touting how bad AVCT are & how he knew (on the ODX board and here).
The planet is full of them.....
@Amateur.invest, I suspect @MB knows this - I don't think he is that naïve business wise (I hope not, the amount he advises on ODX!). He's just on a wind up here - seems to keep him amused for some perverse reason.
"I've checked every other possible company no one is going through home use approval other than ODX. Not antigen or antibody."
Sounds like you know nothing about anything..... (plonker, and also ramper)
@Kainos - agreed.
@MB - hope I haven't come across too aggressive towards you. We're all in this together, both fighting the virus & hoping to do well with our investments
Everyone?
That's not my memory, was just a few.
A few were honestly in sympathy with ODX as AVACT had been in the same place recently.
But don't you see, if you do it, others will respond?
I have to agree with you however, if you were called out by name, that wasn't good.
@Merchantbanker:
"Sorry im not the main instigator, I AM MORE THAN HAPPY TO KEEP MY COMMENTS OF EACH STOCK SPECIFIC TO EACH STOCK, but if others aren't then i will have my say."
"Sorry but the idea of producing tests for Avacta makes very poor commercial sense. When capacity is a limiting factor, why would you produce someone else's tests at SAY (NOT A FACT) 30% margin when you can produce your own branded product at 60%? (GUESS, AGAIN) Sorry but linking ODX manufacturing capacity Avacta's test doesn't add up commercially (GUESS, AGAIN). Especially when there is zero evidence that their test will ever reach commercialisation (KNOCKING AVACTA AGAIN, LOADED PHRASE, NO FACTS ("zero evidence")). If anyone that watched today's presentation thinks that Avacta is the key to our success you need to give up investing (KNOCKING AVACTA AGAIN)."
So you are not the main instigator? but you want the last word, and to continue it. I despair.......
Fyi, all posters on both boards were happy this morning, no bad blood, until @MB went onto the AVCT board and provoked them for no reason?
Actually, not deramping and I'm invested here (quite a lot for me and for a long time - hurt a bit today but it will come back up).
Just like facts & honesty.